A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Kappa Bioscience®

Company-logo  COMPANY DETAILS
Kappa Bioscience®
Silurveien 2, Building B
Oslo
0380
Norway
Website
Mail

HEALTH CATEGORIES

cardiovascular health; general health and wellness; immune health; mobility; sports nutrition; supplements


Linkedin   
Twitter   

Kappa Bioscience® AS is a leading manufacturer of pure, all-bioactive vitamin K2 MK-7 under the K2VITAL® brand, the reference standard for the United States Pharmacopeia - used globally as the benchmark for vitamin K2 analysis and cis/trans purity assessments. Founded and headquartered in Oslo, Norway, the company recently became part of Balchem Corporation, a US-based global specialty ingredients company focused on Nutrition and Health.


By providing 99.7% all-trans vitamin K2 MK-7 – identical to the K2 molecule found in nature and fully bioactive - with unmatched purity and stability, patented processes and innovative technologies, Kappa Bioscience® aims to bring the best possible health benefits to consumers around the world supporting bone and cardiovascular health, healthy ageing and immune health among others.


Kappa Bioscience® provides a full assortment of over 150 vitamin K2 based formulations, backed by consumer research and designed to meet key healthcare needs while shortening development cycles from months to weeks – or even days. K2VITAL® can be used in all relevant dosage forms from tablets to soft-gels, powders to liquids, and even gummies and oral sprays.  K2VITAL® DELTA is a proprietary microencapsulated solution for complete stability in any environment and ideal for pairing with other ingredients, such as vitamin D, calcium, magnesium, omega-3, probiotics and botanicals. 


Kappa Bioscience® believes in better health for all, which can only be achieved through close and open collaboration. The company works with partner network of health & nutrition brands, contract manufacturing organisations and distributors around the globe, to help the health and nutrition industry turn a corner, without cutting corners.


Through Kappa Solutions, the company offers a completely integrated range of organic chemistry and analytical services, cGMP certified labs and unmatched knowledge of vitamin K2. 


From turn-key solutions, product launches and growth strategies, to support with label claims, research and marketing initiatives, Kappa Bioscience® believes in doing it right. That means developing products and services that set new standards of excellence, made with integrity, and through close collaboration. 


Products / Markets supplier image Click to Enlarge

K2VITAL® - a patented, 99.7% all-trans K2 MK-7 that is identical to the K2 molecule found in nature and fully bioactive, so everyone gets the best possible benefits for their bones, heart, and body.


K2VITAL® DELTA - the only double-encapsulated vitamin K2. Just like K2VITAL®, DELTA is pure, all-trans vitamin K2 MK-7. However, DELTA is double-coated beadlet microencapsulation, making it resistant to harsh environments and ideal for pairing with minerals.



Articles On Nutrition Insight
Older man runs by a river.

NUTRITION & HEALTH NEWS

The future of bone health: A deep dive into emerging trends, innovations and ingredients

29 Feb 2024 --- The challenges of a growing aging population can be felt across the globe, and experts point out that more and more consumers are looking to prepare for the effects at younger and... Read More

Athletic woman making a sports nutrition smoothie.

NUTRITION & HEALTH NEWS

Balchem spots innovation opportunities in multifunctional, science-backed sports nutrition

20 Feb 2024 --- In a category that is no longer confined to pro athletes, Balchem points to manufacturers’ need to balance consumer demand for convenient products with efficacy, highlighting... Read More

Vitamin K2 MK-7

NUTRITION & HEALTH NEWS

Kappa Bioscience’s vitamin K2 MK-7 linked to reduced heart disease risk

02 Feb 2024 --- Recent cardiovascular health research demonstrates the considerable potential of vitamin K2 MK-7 as a viable heart health supplement, according to the findings of a peer-reviewed... Read More

A green graphic which says Industry Review 2023 in white.

NUTRITION & HEALTH NEWS

Nutrition industry review 2023: Mega-mergers, ingredient innovations, future-proofing nutrition

12 Dec 2023 --- As we look forward to ringing in the new year, Nutrition Insight revisits some of the biggest news stories of 2023. From innovative “organ-on-a-chip” advancements to... Read More

Knee diagram.

NUTRITION & HEALTH NEWS

Balchem’s OptiMSM reduces knee joint discomfort in healthy adults, clinical study suggests

05 Dec 2023 --- A clinical study conducted in Japan on the use of OptiMSM, the Balchem Human Nutrition & Health brand of methylsulfonylmethane (MSM), demonstrates a significant reduction in... Read More




Videos
FormattedPicture

Balchem’s five-year plan spotlights cross-selling and consumer awareness

04 Jul 2023 --- Balchem has defined a new five-year growth strategy on the heels of its acquisition of Kappa Bioscience and Bergstrom Nutrition, which added K2Vital and OptiMSM to its portfolio. Frederic Boned, senior vice president-general manager at Balchem, reveals how the company is “unlocking new potential” by cross-selling branded ingredients, bringing more awareness to the market and expanding internationally.

FormattedPicture

“The forgotten vitamin”: K2’s bioactive difference from K1

09 Nov 2021 --- Recent science is propelling vitamin K2 into the spotlight as a crucial micronutrient that is missing from the Western diet. Dominik Mattern, vice president marketing at Kappa Bioscience, details its role in combination with D3 in the calcium metabolism. He also explains that widespread confusion with K1 has limited K2’s reach, despite its “very different” bioactivity.

FormattedPicture

How to tap into growing understanding of vitamin K2

05 Jun 2019 --- The growing body of scientific evidence and consumer understanding supporting the benefits of vitamin K2 is providing suppliers with increased options for NPD. At Vitafoods Europe 2019, NutritionInsight spoke with Egil Greve, CEO at Kappa Bioscience AS, about innovative prototypes and product formats.

FormattedPicture

Growing the market for vitamin K2

05 Mar 2019 --- At Nutraceuticals Europe in Madrid, Spain, Maren Janecke, Senior Sales Manager at Kappa Bioscience, explains the growing market potential and consumer interest for vitamin K2. 




Technical Papers
FormattedPicture

K2VITAL® guide: Master the art of vitamin K2 formulation

11 Dec 2023 --- The vitamin K2 market is set to grow by 14.6% every year from 2023 to 2030. But finding the right solution isn’t easy – with common stability and bioavailability issues to watch out for. To help you navigate the market, Balchem has created this handy K2 guide.This Technical Paper is from Kappa Bioscience, a Balchem company. 




Podcasts
FormattedPicture

NewsBite Podcast (Jul 19-23): “Pandemic stress causes ‘alarming’ use of supplements, reveals survey”

26 Jul 2021 --- This week’s NewsBite podcast details how COVID-19 has had a major impact on consumer habits around supplementation, with NPD tackling everything from weight management to immunity. Additionally, Kappa Bioscience investigated the link between COVID-19 outcomes and levels of vitamins D and K2.

FormattedPicture

NewsBite Podcast (Jun 14-18): “Vitamin consumers turn to Seneque’s NMN supplements to boost cellular health”

21 Jun 2021 --- The last week saw developments in boosting cellular health with NMN supplements and untangling the connection between COVID-19 mortality and vitamin K2. In the D2C space, Probi is set to provide Swedish cosmetics company Oriflame its first gut health probiotic, while Unilever acquired Paula’s Choice skincare.

FormattedPicture

NewsBite Podcast (Feb 8-12): “Cargill leads US$55M funding round for Evolve BioSystems’ infant nutrition probiotic”

15 Feb 2021 --- During the last week, Evolve BioSystems landed US$55 million for the commercialization of its “next generation of probiotic.” Other top stories include Lonza’s US$4.7 billion sale of its Speciality Ingredients business and Kappa Bioscience’s US expansion of its vitamin K2 production.

FormattedPicture

NewsBite Podcast (November 16-20): “Persona Nutrition expands personalized supplements, Innova Market Insights details Tailored to Fit trend”

23 Nov 2020 --- This week’s NutritionInsight NewsBite podcast details the personalization trend, which is ushering in a new norm for bespoke foods, beverages and supplements, according to Innova Market Insights. Tapping into that same trend, Persona Nutrition expanded its supplements portfolio to address sleep, energy, stress and immunity in novel capsule designs. Read MorePersona expands line of personalized supplements to boost sleep, energy, stress and immunityTailored to fit: Innova Market Insights spotlights “ever-expanding” personalized nutritionKappa Bioscience supports research on vitamin K deficiency and COVID-19 severity link




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W